drugset / Trial / NCT05021809

Assessment of Postoperative Pain After Using Two Formulations of Calcium Hydroxide Intracanal Medication .

NCT05021809

Phase 4 Unknown 60 enrolled Suez Canal University
RandomizedParallel-groupSingle-blindTreatment

Summary

Calcium hydroxide is advocated as an intracanal medication for various purposes, including prevention of post-treatment symptoms. Calcium hydroxide has a pain-controlling effect at different times when compared to non-intracanal medication . Aim: The aim of the study to compare between postoperative pain after using two formulations of calcium hydroxide intracanal medication with and without iodoform .

Timeline

Start
2021-07-25
Primary completion
2022-09
Completion
2022-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium Hydroxide Other / unclassified Other